Suraksha Diagnostic IPO
mainboardlistedAbout the company
Suraksha Diagnostic provides integrated pathology, radiology testing, and medical consultation services through its extensive network of 49 diagnostic centres, 8 labs, and 166 sample collection points across eastern India. Offering over 2,300 tests, including specialised pathology and advanced radiology, Suraksha Diagnostic serves over 1 million patients annually. With 750+ doctors providing consultations at polyclinics, the company ensures comprehensive care.
Strengths
Risks
Financial performance (₹ Cr)
IPO Roadmap / Timeline
IPO Opens
Completed29 Nov 2024Bidding starts for all investor categories
IPO Closes
Completed03 Dec 2024Last day to place your bid
Basis of Allotment
Completed04 Dec 2024Share allotment finalised
Refund Initiation
Completed05 Dec 2024Refunds credited for non-allottees
Credit to Demat
Completed05 Dec 2024Allotted shares credited to demat account
Listing on Exchange
Completed06 Dec 2024Shares list on NSE / BSE
Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.
Lot size & minimum investment
| Investor Type | Min Lots | Min Shares | Min Amount | Max Lots | Max Amount | Notes |
|---|---|---|---|---|---|---|
| Retail | 1 | 34 | ₹14,994 | 13 | ₹194,922 | ≤ ₹2,00,000 |
| sHNI (Small HNI) | 14 | 476 | ₹209,916 | 66 | ₹989,604 | ₹2L – ₹10L |
| bHNI (Big HNI) | 67 | 2278 | ₹1,004,598 | 72 | ₹1,079,568 | > ₹10L |
Shares reserved per category & allotment probability
| Category | Reservation | Shares Offered | Amount (₹ Cr) | Shares Bid | Subscribed | Allotment % |
|---|---|---|---|---|---|---|
| QIB | 50% | 0 | 0 | 0 | 0.00x | 100% |
| NII | 15% | 0 | 0 | 0 | 0.00x | 100% |
| Retail | 35% | 0 | 0 | 0 | 0.00x | 100% |
Retail is a lottery-based allotment when oversubscribed; QIB/NII get pro-rata. Probability ≈ 1 / subscription times (100% if under-subscribed).
